SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility
SOHM, Inc. (OTCID:SHMN) announced the relocation of its operations to a new 24,000 square-foot commercialization facility in Vista, California. The strategic facility features a 50-50 split between office/lab space and warehouse space, designed to support manufacturing, R&D, and biotech commercialization activities.
Located at 1396 Poinsettia Avenue within the Poinsettia Business Park, this expansion aims to accelerate SOHM's growth strategy, support new product launches, and strengthen its presence in high-growth healthcare markets. The company expects the move to enhance operational efficiency, streamline product development, and facilitate new partnerships within Southern California's life sciences ecosystem.
SOHM, Inc. (OTCID:SHMN) ha annunciato il trasferimento delle proprie attività in una nuova struttura commerciale di 24.000 piedi quadrati a Vista, California. La struttura strategica è organizzata con una suddivisione 50-50 tra spazi per uffici/laboratorio e magazzino, pensata per supportare produzione, ricerca e sviluppo e attività di commercializzazione biotecnologica.
Situata al 1396 Poinsettia Avenue nel Poinsettia Business Park, questa espansione mira ad accelerare la strategia di crescita di SOHM, sostenere il lancio di nuovi prodotti e rafforzare la sua presenza nei mercati sanitari in rapida espansione. L'azienda ritiene che il trasferimento migliorerà l'efficienza operativa, snellirà lo sviluppo dei prodotti e faciliterà nuove collaborazioni nell'ecosistema delle scienze della vita della California meridionale.
SOHM, Inc. (OTCID:SHMN) anunció la reubicación de sus operaciones a una nueva instalación de comercialización de 24.000 pies cuadrados en Vista, California. La instalación estratégica cuenta con una división 50-50 entre espacio de oficinas/laboratorio y espacio de almacén, diseñada para apoyar la fabricación, I+D y actividades de comercialización biotecnológica.
Ubicada en 1396 Poinsettia Avenue dentro del Poinsettia Business Park, esta ampliación tiene como objetivo acelerar la estrategia de crecimiento de SOHM, respaldar el lanzamiento de nuevos productos y fortalecer su presencia en mercados sanitarios de alto crecimiento. La compañía espera que la mudanza mejore la eficiencia operativa, agilice el desarrollo de productos y facilite nuevas asociaciones dentro del ecosistema de ciencias de la vida del sur de California.
SOHM, Inc. (OTCID:SHMN)는 캘리포니아주 비스타에 있는 24,000평방피트 규모의 신규 상업시설로 운영을 이전한다고 발표했습니다. 이 전략적 시설은 사무실/실험실 공간과 창고 공간을 50:50으로 나눠 제조, 연구개발(R&D) 및 바이오텍 상업화 활동을 지원하도록 설계되었습니다.
1396 Poinsettia Avenue의 Poinsettia Business Park에 위치한 이번 확장은 SOHM의 성장 전략 가속화, 신제품 출시 지원 및 고성장 의료 시장에서의 입지 강화가 목적입니다. 회사는 이전을 통해 운영 효율성이 향상되고 제품 개발이 간소화되며 남부 캘리포니아 생명과학 생태계 내에서 새로운 파트너십이 촉진될 것으로 기대하고 있습니다.
SOHM, Inc. (OTCID:SHMN) a annoncé le transfert de ses activités dans une nouvelle installation commerciale de 24 000 pieds carrés à Vista, en Californie. L'installation stratégique est répartie à parts égales entre des espaces bureaux/laboratoire et des espaces d'entrepôt, conçue pour soutenir la production, la R&D et les activités de commercialisation en biotechnologie.
Située au 1396 Poinsettia Avenue dans le Poinsettia Business Park, cette expansion vise à accélérer la stratégie de croissance de SOHM, à soutenir les lancements de nouveaux produits et à renforcer sa présence sur des marchés de santé à forte croissance. L'entreprise estime que ce déménagement améliorera l'efficacité opérationnelle, rationalisera le développement des produits et facilitera de nouveaux partenariats au sein de l'écosystème des sciences de la vie du sud de la Californie.
SOHM, Inc. (OTCID:SHMN) gab bekannt, dass es seinen Betrieb in eine neue 24.000 Quadratfuß große Kommerzialisierungsanlage in Vista, Kalifornien, verlegt. Die strategische Anlage ist zu 50 % als Büro/Labor und zu 50 % als Lagerfläche ausgelegt und soll Fertigung, F&E und Biotech-Commercialisierungsaktivitäten unterstützen.
Die Erweiterung am 1396 Poinsettia Avenue im Poinsettia Business Park soll SOHMs Wachstumsstrategie beschleunigen, Produkteinführungen unterstützen und die Präsenz in stark wachsenden Gesundheitsmärkten stärken. Das Unternehmen erwartet, dass der Umzug die operative Effizienz verbessert, die Produktentwicklung strafft und neue Partnerschaften im Life-Sciences-Ökosystem Südkaliforniens erleichtert.
- Expansion to larger 24,000 square-foot facility with specialized biotech capabilities
- Strategic location in Southern California's biotech hub enabling new partnership opportunities
- Enhanced operational infrastructure supporting faster product commercialization
- Flexible facility layout with balanced office/lab and warehouse space
- Potential relocation costs and operational disruption during transition
- Increased operational expenses from larger facility
CHINO HILLS, CA / ACCESS Newswire / September 2, 2025 / SOHM, Inc. (OTCID:SHMN), a leading pharmaceutical company developing next-generation gene editing solutions, today announced the relocation of its operations to a newly outfitted commercialization facility at 1396 Poinsettia Avenue, Vista, California.
SOHM will have ample specialized space within the 24,000 square-foot industrial building, which is part of the Poinsettia Business Park and features a flexible layout designed to support manufacturing, research and development, and biotech commercialization. With
"This strategic move represents a major milestone in SOHM's roadmap toward scaling operations and driving shareholder value," said David Aguilar, PhD, Chief Operating Officer of SOHM, Inc. "The Vista facility provides the infrastructure we need to bring products from concept to commercialization faster, while positioning us in one of the strongest biotech hubs in the United States. We are confident this investment will strengthen our ability to deliver returns through innovation and market expansion."
The relocation is expected to enhance operational efficiency, streamline product development pipelines, and enable new partnerships within Southern California's thriving life sciences ecosystem. SOHM views the expansion as a foundation for its long-term growth strategy, supporting both organic development and potential strategic acquisitions in the biotech and healthcare sectors.
About SOHM, Inc.:
SOHM is a biopharmaceutical company dedicated to developing and commercializing gene editing technologies for research, synthetic biology, and therapeutic applications. With a focus on precision medicine, SOHM aims to revolutionize the treatment of genetic diseases by providing safe, efficient, and targeted solutions for gene editing. Through strategic collaborations and groundbreaking research, SOHM is at the forefront of advancing the field of gene therapy. SOHM strives to transform the landscape of genome editing and improve the quality of life through scientific discovery.
For further information regarding this announcement or to explore potential collaborations, please contact:
SOHM, Inc.:
Name: Baron Night, CEO/Dr. David Aguilar, COO
Email: info@sohm.com
Phone: (714) 522-6700
Safe Harbor Statement:
This news release contains "forward-looking statements," which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development-stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time to time on OTCMarkets.com.
SOURCE: SOHM, Inc
View the original press release on ACCESS Newswire
FAQ
Where is SOHM Inc's new facility located?
How large is SOHM's new Vista, CA facility?
What is the purpose of SOHM's facility expansion?
How will the new facility benefit SOHM's operations?
What type of space distribution does SOHM's new facility have?
